Christine Kharasch
Family Medicine · Lindenhurst, ILNPI 1386643047
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 9.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $711 and has fallen 97.5% since, to $18 in 2024.
Across 89 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$145
- Sanofi-aventis U.S. LLC$142
- Boehringer Ingelheim$107
- Novo Nordisk$98
- Takeda Pharmaceuticals U.S.A., Inc.$97
- AbbVie$86
- plus $834 from 21 others
What the payments were for
- Food & beverage$1,509100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $145 |
| Sanofi-aventis U.S. LLC | 9 | $142 |
| Boehringer Ingelheim | 5 | $107 |
| Novo Nordisk | 6 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $97 |
| AbbVie(2 entities) | 5 | $86 |
| Sanofi Pasteur Inc. | 4 | $84 |
| Lilly USA, LLC | 5 | $75 |
| Merck | 5 | $74 |
| Pfizer | 4 | $74 |
| Johnson & Johnson(2 entities) | 3 | $59 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $49 |
| Biohaven Pharmaceuticals, Inc. | 3 | $49 |
| Adlon Therapeutics L.p. | 3 | $45 |
| Amarin Pharma, Inc. | 2 | $45 |
| GSK | 3 | $40 |
| AstraZeneca | 3 | $39 |
| IBSA Pharma Inc. | 2 | $37 |
| Currax Pharmaceuticals LLC | 2 | $32 |
| Nalpropion Pharmaceuticals LLC | 2 | $22 |
| Neos Therapeutics, LP | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Abbott | 1 | $18 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Eisai Inc. | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
How this compares
$1,509 in reported general payments places this provider in the 75th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Lindenhurst
- Thomas McGowanLindenhurst$21K
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.